Oral Testosterone Ester Composition for Treating Liver Diseases
Summary
The European Patent Office granted Patent EP3824296A1 to Lipocine Inc. covering an oral pharmaceutical composition comprising testosterone tridecanoate and/or testosterone dodecanoate for treating liver diseases. The patent designates 33 European Patent Convention states including Germany, France, the United Kingdom, Italy, and Spain. Inventors include Patel, Chidambaram, Nachaegari, Byrne, Kim, and Baker.
What changed
EPO granted patent EP3824296A1 to Lipocine Inc. covering oral pharmaceutical compositions containing testosterone tridecanoate and/or testosterone dodecanoate for treating liver diseases (A61P 1/16). The patent application was published under the A1 kind code indicating it includes the search report.
Pharmaceutical companies developing liver disease treatments should review this patent for potential freedom-to-operate concerns. Competitors in the testosterone or liver disease therapeutic space should monitor this IP family for potential overlap with their own development programs. Patent prosecution history may provide insights into claim scope and examiner positions during examination.
What to do next
- Monitor patent portfolio for potential licensing opportunities
- Review freedom-to-operate landscape for competing liver disease therapies
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ORAL PHARMACEUTICAL COMPOSITION COMPRISING TESTOSTERONE TRIDECANOATE AND/OR TESTOSTERONE DODECANOATE FOR TREATING LIVER DISEASES
Publication EP3824296A1 Kind: A1 Apr 01, 2026
Applicants
Lipocine Inc.
Inventors
PATEL, Mahesh V., CHIDAMBARAM, Nachiappan, NACHAEGARI, Satish K., BYRNE, Burke, KIM, Kilyoung, BAKER, Jonathan A.
IPC Classifications
A61K 31/201 20060101AFI20251027BHEP A61K 31/355 20060101ALI20251027BHEP A61K 31/568 20060101ALI20251027BHEP G01N 33/74 20060101ALI20251027BHEP H01J 49/00 20060101ALI20251027BHEP A61P 1/16 20060101ALI20251027BHEP G01N 33/68 20060101ALI20251027BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.